MGRX
Mangoceuticals, Inc.
Price Chart
Latest Quote
$0.35
+0.06 (+19.24%)
Current Price
| Previous Close | $0.29 |
| Open | $0.29 |
| Day High | $0.36 |
| Day Low | $0.27 |
| Volume | 9,037,492 |
Stock Information
| Shares Outstanding | 17.17M |
| Total Debt | $294K |
| Cash Equivalents | $175K |
| Revenue | $415K |
| Net Income | $-20.38M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $6.16M |
| EPS (TTM) | $-1.27 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $6.08M |
| Sales | $415K |
| Income | $-20.38M |
| Book/sh | $0.79 |
| Cash/sh | $0.01 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 0.24 |
| Current Ratio | 0.29 |
| Debt/Eq | 2.18 |
Returns & Margins
| ROA | -60.60% |
| ROE | -113.90% |
| Gross Margin | 52.42% |
| Operating Margin | -4588.41% |
Ownership
| Insider Ownership | 10.04% |
| Institutional Ownership | 4.81% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 14.87 |
| P/B | 0.45 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.37 |
| SMA50 | $0.39 |
| SMA200 | $0.97 |
| RSI | 46.88 |
| ATR | 0.0435 |
| Shares Float | 13.43M |
| Short Float | 1.50% |
| Short Ratio | 0.28 |
| Volatility | 2.27 |
| Rel Volume | 0.43 |
Performance History
| Week | +7.49% |
| Month | -20.40% |
| Quarter | +18.48% |
| 6 Months | -49.65% |
| YTD | -57.91% |
| Year | -80.70% |
| 3 Years | -98.51% |
| 10 Years | -99.40% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $0.36 | 995,593 |
| 2026-06-23 | $0.35 | 10,172,400 |
| 2026-06-22 | $0.29 | 29,654,800 |
| 2026-06-18 | $0.32 | 440,400 |
| 2026-06-17 | $0.33 | 151,300 |
| 2026-06-16 | $0.33 | 177,500 |
| 2026-06-15 | $0.36 | 302,400 |
| 2026-06-12 | $0.36 | 211,300 |
| 2026-06-11 | $0.37 | 176,000 |
| 2026-06-10 | $0.36 | 279,800 |
| 2026-06-09 | $0.34 | 138,400 |
| 2026-06-08 | $0.36 | 132,000 |
| 2026-06-05 | $0.36 | 363,700 |
| 2026-06-04 | $0.39 | 257,800 |
| 2026-06-03 | $0.38 | 147,600 |
| 2026-06-02 | $0.38 | 1,024,800 |
| 2026-06-01 | $0.42 | 584,700 |
| 2026-05-29 | $0.43 | 430,600 |
| 2026-05-28 | $0.48 | 527,600 |
| 2026-05-27 | $0.50 | 461,400 |
| 2026-05-26 | $0.55 | 1,266,000 |
About Mangoceuticals, Inc.
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
đ° Latest News
BC-Most Active Stocks
Associated Press Finance âĸ 2026-03-23T14:30:19ZTop Midday Decliners
MT Newswires âĸ 2025-12-19T18:46:56ZEli Lilly and Novo Nordisk disown Mangoceuticalsâ GLP-1RA partnership claim
Pharmaceutical Technology âĸ 2025-11-14T13:00:41Z
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs
Reuters âĸ 2025-11-14T01:51:11Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $205,635 | $225,973 | $220,124 | $4,089 |
| Cost Of Revenue | $205,635 | $235,909 | $299,992 | $4,089 |
| Total Revenue | $456,021 | $615,873 | $731,493 | $8,939 |
| Operating Revenue | $456,021 | $615,873 | $731,493 | $8,939 |
| Expenses | ||||
| Interest Expense | $103,513 | $13,700 | $0 | $6,473 |
| Total Expenses | $19,611,009 | $9,309,399 | $9,950,383 | $2,000,521 |
| Other Income Expense | $-1,384,954 | - | $6,473 | - |
| Net Non Operating Interest Income Expense | $-103,513 | $-13,700 | $0 | $-6,473 |
| Interest Expense Non Operating | $103,513 | $13,700 | $0 | $6,473 |
| Operating Expense | $19,405,374 | $9,073,490 | $9,650,391 | $1,996,432 |
| Other Operating Expenses | $1,561,206 | $453,749 | $1,100,465 | - |
| Selling And Marketing Expense | $822,860 | $1,478,663 | $2,097,505 | $352,860 |
| General And Administrative Expense | $15,898,669 | $6,419,545 | $6,452,421 | $1,643,572 |
| Other Non Operating Income Expenses | - | - | $6,473 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-20,642,994 | $-8,706,145 | $-9,212,417 | $-1,998,055 |
| Net Interest Income | $-103,513 | $-13,700 | $0 | $-6,473 |
| Normalized Income | $-19,258,040 | $-8,706,145 | $-9,212,417 | $-1,998,055 |
| Net Income From Continuing And Discontinued Operation | $-20,642,994 | $-8,706,145 | $-9,212,417 | $-1,998,055 |
| Total Operating Income As Reported | $-18,032,349 | $-7,971,993 | $-9,218,890 | $-1,991,582 |
| Net Income Common Stockholders | $-21,818,994 | $-9,508,254 | $-9,212,417 | $-1,998,055 |
| Net Income | $-20,642,994 | $-8,706,145 | $-9,212,417 | $-1,998,055 |
| Net Income Including Noncontrolling Interests | $-20,643,455 | $-8,707,226 | $-9,212,417 | $-1,998,055 |
| Net Income Continuous Operations | $-20,643,455 | $-8,707,226 | $-9,212,417 | $-1,998,055 |
| Pretax Income | $-20,643,455 | $-8,707,226 | $-9,212,417 | $-1,998,055 |
| Special Income Charges | $-1,384,954 | $0 | - | - |
| Operating Income | $-19,154,988 | $-8,693,526 | $-9,218,890 | $-1,991,582 |
| Depreciation Amortization Depletion Income Statement | $1,122,639 | $721,533 | $0 | - |
| Depreciation And Amortization In Income Statement | $1,122,639 | $721,533 | $0 | - |
| Amortization Of Intangibles Income Statement | $1,122,639 | $721,533 | $0 | - |
| Gross Profit | $250,386 | $379,964 | $431,501 | $4,850 |
| Per Share | ||||
| Diluted EPS | $-2.17 | $-4.80 | $-8.58 | $-1.96 |
| Basic EPS | $-2.17 | $-4.80 | $-8.58 | $-1.96 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-17,430,785 | $-7,962,057 | $-9,132,549 | $-1,987,719 |
| Total Unusual Items | $-1,384,954 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $-1,384,954 | $0 | - | - |
| Reconciled Depreciation | $1,724,203 | $731,469 | $79,868 | $3,863 |
| EBITDA (Bullshit earnings) | $-18,815,739 | $-7,962,057 | $-9,132,549 | $-1,987,719 |
| EBIT | $-20,539,942 | $-8,693,526 | $-9,212,417 | $-1,991,582 |
| Diluted Average Shares | $10,071,609 | $1,978,966 | $1,074,202 | $1,021,000 |
| Basic Average Shares | $10,071,609 | $1,978,966 | $1,074,202 | $1,021,000 |
| Diluted NI Availto Com Stockholders | $-21,818,994 | $-9,508,254 | $-9,212,417 | $-1,998,055 |
| Preferred Stock Dividends | $1,176,000 | $802,109 | - | - |
| Minority Interests | $461 | $1,081 | $0 | - |
| Tax Provision | $0 | $0 | $0 | $0 |
| Other Special Charges | $145,012 | - | - | - |
| Impairment Of Capital Assets | $1,239,942 | - | - | - |
| Amortization | $1,122,639 | $721,533 | $0 | - |
| Selling General And Administration | $16,721,529 | $7,898,208 | $8,549,926 | $1,996,432 |
| Other Gand A | $3,756,373 | $3,000,571 | $3,319,417 | $1,643,572 |
| Salaries And Wages | $12,142,296 | $3,418,974 | $3,133,004 | $0 |
Fetched: 2026-06-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $968,063 | $-1,286,488 | $774,754 | $614,030 |
| Total Assets | $16,089,573 | $15,370,511 | $1,050,793 | $1,003,287 |
| Total Non Current Assets | $14,542,139 | $15,294,916 | $215,391 | $308,682 |
| Goodwill And Other Intangible Assets | $14,232,484 | $15,232,617 | $0 | - |
| Other Intangible Assets | $14,232,484 | $15,232,617 | - | - |
| Current Assets | $1,547,434 | $75,595 | $835,402 | $694,605 |
| Prepaid Assets | $41,040 | $16,942 | $77,895 | $11,745 |
| Receivables | $20,056 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $1,486,338 | $58,653 | $739,006 | $682,860 |
| Cash And Cash Equivalents | $1,486,338 | $58,653 | $739,006 | $682,860 |
| Cash Financial | $1,486,338 | $58,653 | $739,006 | - |
| Inventory | - | $0 | $18,501 | $0 |
| Non Current Prepaid Assets | - | - | $16,942 | $16,942 |
| Debt | ||||
| Total Debt | $307,823 | $214,962 | $128,679 | $352,865 |
| Current Debt And Capital Lease Obligation | $307,823 | $214,962 | $63,718 | $224,185 |
| Net Debt | - | $91,347 | - | - |
| Long Term Debt And Capital Lease Obligation | - | $0 | $64,961 | $128,680 |
| Current Debt | - | $150,000 | - | $167,460 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $890,568 | $1,425,463 | $276,039 | $389,257 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $64,961 | $128,680 |
| Current Liabilities | $890,568 | $1,425,463 | $211,078 | $260,577 |
| Current Notes Payable | $0 | $150,000 | $0 | $167,460 |
| Payables And Accrued Expenses | $582,745 | $1,210,501 | $147,360 | $36,392 |
| Payables | $582,745 | $1,210,501 | $147,360 | $36,392 |
| Other Payable | $156,642 | $373,000 | - | - |
| Total Tax Payable | $9,421 | $0 | $6,595 | $2,717 |
| Accounts Payable | $416,682 | $837,501 | $140,765 | $33,675 |
| Equity | ||||
| Common Stock Equity | $15,200,449 | $13,946,031 | $774,754 | $614,030 |
| Preferred Stock Equity | $98 | $98 | - | - |
| Total Equity Gross Minority Interest | $15,199,005 | $13,945,048 | $774,754 | $614,030 |
| Stockholders Equity | $15,200,547 | $13,946,129 | $774,754 | $614,030 |
| Other Equity Interest | $324,288 | $-825,712 | - | - |
| Gains Losses Not Affecting Retained Earnings | $-2,760 | $-9,845 | $0 | - |
| Other Equity Adjustments | $-2,760 | $-9,845 | - | - |
| Retained Earnings | $-40,647,480 | $-20,004,486 | $-11,228,173 | $-2,015,756 |
| Other | ||||
| Ordinary Shares Number | $15,888,795 | $3,245,641 | $1,427,966 | $1,021,000 |
| Share Issued | $15,888,795 | $3,245,641 | $1,427,966 | $1,021,000 |
| Tangible Book Value | $967,965 | $-1,286,586 | $774,754 | $614,030 |
| Invested Capital | $15,200,449 | $14,096,031 | $774,754 | $781,490 |
| Working Capital | $656,866 | $-1,349,868 | $624,324 | $434,028 |
| Capital Lease Obligations | $307,823 | $64,962 | $128,679 | $185,405 |
| Total Capitalization | $15,200,547 | $13,946,129 | $774,754 | $614,030 |
| Minority Interest | $-1,542 | $-1,081 | $0 | - |
| Additional Paid In Capital | $55,524,812 | $34,785,749 | $12,002,779 | $2,628,449 |
| Capital Stock | $1,687 | $423 | $148 | $1,337 |
| Common Stock | $1,589 | $325 | $148 | $1,337 |
| Preferred Stock | $98 | $98 | $0 | - |
| Current Capital Lease Obligation | $307,823 | $64,962 | $63,718 | $56,725 |
| Net PPE | $309,655 | $62,299 | $215,391 | $291,740 |
| Accumulated Depreciation | $-3,268 | $-2,256 | $-28,752 | $-3,863 |
| Gross PPE | $312,923 | $64,555 | $244,143 | $295,603 |
| Other Properties | $307,861 | $59,493 | $239,081 | $290,541 |
| Machinery Furniture Equipment | $5,062 | $5,062 | $5,062 | $5,062 |
| Duefrom Related Parties Current | $20,056 | $0 | - | - |
| Long Term Capital Lease Obligation | - | $0 | $64,961 | $128,680 |
| Finished Goods | - | $0 | $18,501 | - |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-06-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,850,255 | $-4,863,776 | $-7,000,894 | $-1,389,620 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,850,255 | $-4,863,776 | $-6,997,375 | $-1,346,518 |
| Cash Flow From Continuing Operating Activities | $-5,850,255 | $-4,863,776 | $-6,997,375 | $-1,346,518 |
| Operating Gains Losses | $145,012 | $18,387 | - | $-151,821 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $65,000 | $-3,519 | $-43,102 |
| Cash Flow From Continuing Investing Activities | $0 | $65,000 | $-3,519 | $-43,102 |
| Net Other Investing Changes | - | $65,000 | - | - |
| Capital Expenditure | - | - | $-3,519 | $-43,102 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,725,355 | $3,978,268 | $6,200,000 | $2,000,000 |
| Financing Cash Flow | $7,270,855 | $4,128,268 | $7,057,040 | $2,049,930 |
| Cash Flow From Continuing Financing Activities | $7,270,855 | $4,128,268 | $7,057,040 | $2,049,930 |
| Net Other Financing Charges | $1,150,000 | - | - | - |
| Net Preferred Stock Issuance | $100,000 | $2,650,000 | $0 | - |
| Preferred Stock Issuance | $100,000 | $2,650,000 | $0 | - |
| Net Common Stock Issuance | $4,625,355 | $1,328,268 | $6,200,000 | $2,000,000 |
| Common Stock Issuance | $4,625,355 | $1,328,268 | $6,200,000 | $2,000,000 |
| Other | ||||
| Repayment Of Debt | $-206,500 | $0 | $-167,460 | $-25,070 |
| Issuance Of Debt | $675,000 | $150,000 | $0 | $75,000 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $1,486,338 | $58,653 | $739,006 | $682,860 |
| Beginning Cash Position | $58,653 | $739,006 | $682,860 | $22,550 |
| Effect Of Exchange Rate Changes | $7,085 | $-9,845 | $0 | - |
| Changes In Cash | $1,420,600 | $-670,508 | $56,146 | $660,310 |
| Proceeds From Stock Option Exercised | $927,000 | $0 | $1,024,500 | $0 |
| Net Issuance Payments Of Debt | $468,500 | $150,000 | $-167,460 | $49,930 |
| Net Short Term Debt Issuance | $675,000 | $150,000 | $-167,460 | $49,930 |
| Short Term Debt Issuance | $675,000 | $150,000 | $0 | $75,000 |
| Net Long Term Debt Issuance | $-206,500 | $0 | - | - |
| Long Term Debt Payments | $-206,500 | $0 | - | - |
| Change In Working Capital | $-269,468 | $660,377 | $-13,467 | $18,869 |
| Change In Other Current Liabilities | $-290,404 | $-33,595 | $-56,726 | $185,405 |
| Change In Payables And Accrued Expense | $65,090 | $633,019 | $110,968 | $36,392 |
| Change In Accrued Expense | $0 | $-63,717 | - | - |
| Change In Payable | $65,090 | $696,736 | $110,968 | $36,392 |
| Change In Account Payable | $55,669 | $696,736 | $107,090 | $33,675 |
| Change In Tax Payable | $9,421 | $0 | $3,878 | $2,717 |
| Change In Income Tax Payable | $9,421 | $0 | $3,878 | $2,717 |
| Change In Prepaid Assets | $-24,098 | $60,953 | $-49,208 | $-28,687 |
| Change In Receivables | $-20,056 | $0 | $54,979 | $-174,241 |
| Other Non Cash Items | $10,785,231 | $2,166,034 | $1,524,178 | $546,538 |
| Stock Based Compensation | $1,168,280 | $248,682 | $624,463 | $234,088 |
| Asset Impairment Charge | $1,239,942 | $18,501 | $0 | - |
| Depreciation Amortization Depletion | $1,724,203 | $731,469 | $79,868 | $3,863 |
| Depreciation And Amortization | $1,724,203 | $731,469 | $79,868 | $3,863 |
| Amortization Cash Flow | $1,723,191 | $721,533 | $54,979 | - |
| Amortization Of Intangibles | $1,723,191 | $721,533 | $54,979 | - |
| Depreciation | $1,012 | $9,936 | $24,889 | $3,863 |
| Net Income From Continuing Operations | $-20,643,455 | $-8,707,226 | $-9,212,417 | $-1,998,055 |
| Short Term Debt Payments | - | $0 | $-167,460 | $-25,070 |
| Net PPE Purchase And Sale | - | $0 | $-3,519 | $-43,102 |
| Purchase Of PPE | - | $0 | $-3,519 | $-43,102 |
| Change In Inventory | - | $0 | $-18,501 | $0 |
| Gain Loss On Investment Securities | - | - | - | $-151,821 |
Fetched: 2026-06-24